OOIR: Observatory of International Research

Papers

(The TQCC of Biosocieties is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Rethinking value construction in biomedicine and healthcare	15
The emergence of multimorbidity as a matter of concern: a critical review	10
Life’s continuation: repro-tech, biogenetic affinity, and racial capitalism	9
‘We thank you for your sacrifice’: Clinical vulnerability, shielding and biosociality in the UK’s Covid-19 response	9
‘The good economy’: a conceptual and empirical move for investigating how economies and versions of the good are entangled	7
Making valuable health: pharmaceuticals, global capital and alternative political economies	7
Reprowebs: a conceptual approach to elasticity and change in the global assisted reproduction industry	7
“The elephant in the room”: social responsibility in the production of sociogenomics research	6
Psychedelic innovations and the crisis of psychopharmacology	6
To wish you well: the biopolitical subjectivities of medical crowdfunders during and after Aotearoa New Zealand’s COVID-19 lockdown	6
The FDA’s standard-making process for medical digital health technologies: co-producing technological and organizational innovation	6
Value-creation in the health data domain: a typology of what health data help us do	6
Beyond the making of altruism: branding and identity in egg donation websites in Spain	6
Beyond secrecy and openness: telling a relational story about children’s best interests in donor-conceived families	5
Device activism and material participation in healthcare: retracing forms of engagement in the #WeAreNotWaiting movement for open-source closed-loop systems in type 1 diabetes self-care	5
The life and death of confidentiality: a historical analysis of the flows of patient information	5
Fake eggs: from counter-qualification to popular certification in China’s food safety crisis	5
Ectogenesis, inequality, and coercion: a reproductive justice-informed analysis of the impact of artificial wombs	5
The Covid-19 caesura and the post-pandemic future	5
Vegetative value: promissory horizons of therapeutic innovation in the global circulation of ayahuasca	5
Sexual health as surplus: the marketization of PrEP in Taiwan	5
Allostatic load: historical origins, promises and costs of a recent biosocial approach	4
Genome editing: From bioethics to biopolitics	4
Legitimate suffering: a case of belonging and sickle cell trait in Brazil	4
Agri-food tech’s building block: narrating protein, agnostic of source, in the face of crisis	4

Pharmaceutical innovation and its crisis: drug markets, screening, and the dialectics of value	4
Analysing bio-art’s epistemic landscape: from metaphoric to post-metaphoric structure	4
Value regimes and pricing in the pharmaceutical industry: financial capital inflation (hepatitis C) versus innovation and production capital savings for malaria medicines	3
Living in the era of codes: a reflection on China’s health code system	3
Making it happen: data practices and the power of diplomacy among Danish organ transplant coordinators	3
The ongoing work of kinship among donor half-siblings in The Netherlands	3
Discipline for pleasure: a new governmentality of HIV prevention	3
Epigenetic citizenship and political claims-making: the ethics of molecularizing structural racism	3
Adjusting the analytical aperture: propositions for an integrated approach to the social study of reproductive technologies	3
“It’s harder for the likes of us”: racially minoritised stem cell donation as ethico-racial imperative	3